Gsa Capital Partners LLP Eli Lilly & CO Transaction History

Gsa Capital Partners LLP

$1.32 Billion
Q3 2024

A detailed history of Gsa Capital Partners LLP transactions in Eli Lilly & CO stock. As of the latest transaction made, Gsa Capital Partners LLP holds 684 shares of LLY stock, worth $537,781. This represents 0.05% of its overall portfolio holdings.

Number of Shares

684

Holding current value

$537,781

% of portfolio

0.05%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	BUY	$772.14 - $960.02 $528,143 - $656,653	684 New	684 $606,000
Q3 2023 Nov 15, 2023	BUY	$434.7 - $599.3 $1.46 Million - $2.01 Million	3,351 Added 197.93%	5,044 $2.71 Million
Q2 2023 Aug 14, 2023	BUY	$350.74 - $468.98 $593,802 - $793,983	1,693 New	1,693 $793,000
Q4 2022 Feb 13, 2023	BUY	$321.55 - $374.67 $232,480 - $270,886	723 New	723 $265,000
Q2 2022 Aug 09, 2022	SELL	$278.73 - $327.27 $812,219 - $953,664	-2,914 Reduced 48.7%	3,069 $995,000
Q1 2022 May 11, 2022	BUY	$234.69 - $291.66 $1.06 Million - $1.32 Million	4,515 Added 307.56%	5,983 $1.71 Million
Q4 2021 Feb 14, 2022	SELL	$224.85 - $279.04 $115,572 - $143,426	-514 Reduced 25.93%	1,468 $405,000
Q3 2021 Nov 12, 2021	BUY	$221.6 - $272.71 $439,211 - $540,511	1,982 New	1,982 $458,000
Q1 2021 May 10, 2021	SELL	$164.32 - $212.72 $200,634 - $259,731	-1,221 Closed	0 $0
Q4 2020 Feb 03, 2021	SELL	$130.46 - $172.63 $233,132 - $308,489	-1,787 Reduced 59.41%	1,221 $206,000
Q3 2020 Nov 06, 2020	BUY	$146.22 - $169.13 $439,829 - $508,743	3,008 New	3,008 $445,000
Q1 2020 May 12, 2020	SELL	$119.05 - $147.35 $285,720 - $353,640	-2,400 Closed	0 $0
Q4 2019 Feb 12, 2020	SELL	$106.92 - $132.43 $249,337 - $308,826	-2,332 Reduced 49.28%	2,400 $315,000
Q3 2019 Nov 12, 2019	SELL	$106.79 - $116.16 $1.15 Million - $1.26 Million	-10,811 Reduced 69.56%	4,732 $529,000
Q2 2019 Aug 06, 2019	BUY	$110.79 - $129.32 $746,059 - $870,840	6,734 Added 76.44%	15,543 $1.72 Million
Q1 2019 May 15, 2019	SELL	$111.31 - $131.02 $59,216 - $69,702	-532 Reduced 5.7%	8,809 $1.14 Million
Q4 2018 Feb 12, 2019	SELL	$105.9 - $118.64 $122,738 - $137,503	-1,159 Reduced 11.04%	9,341 $1.08 Million
Q3 2018 Nov 13, 2018	BUY	$85.86 - $107.31 $901,530 - $1.13 Million	10,500 New	10,500 $1.13 Million

Others Institutions Holding LLY

# of Institutions

3,994

Shares Held

752M

Call Options Held

7.31M

Put Options Held

9.23M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $747B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Gsa Capital Partners LLP with notifications on news.

Account

Gsa Capital Partners LLP Eli Lilly & CO Transaction History